Athanase Innovation AB (OM: ATIN)
Financials · Capital Markets · SE
Skr—
— today · — 1Y
Athanase Innovation AB (OM: ATIN) operates in the Capital Markets industry within the Financials sector. The company is valued at $38.92M and employs 27 people.
trading between 10.00 and 20.80.
Tweenvest scores Athanase Innovation AB across four factors: quality 36/100, value 60/100. Its strongest factor is value.
ATIN price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $38.92M
- Revenue (TTM)
- $6.29M
- P/E
- —
- EPS
- -2.29
- Dividend yield
- —
- Beta (5Y)
- 0.43
- 52-week high
- Skr20.80
- 52-week low
- Skr10.00
- Avg volume (3M)
- —
- Shares outstanding
- 19.30M
- Employees
- 27
- Next earnings
- —
About Athanase Innovation AB
Established in 2016, Athanase Innovation AB is a Stockholm-based alternative investment firm dedicated to funding businesses that lead the way in robotics, digitalization, and automation within Sweden.
- ISIN
- SE0018014060
- Founded
- 2016
- Listed since
- May 8, 2017
- Exchange
- OMX Nordic Exchange Stockholm
- Currency
- SEK
Other Capital Markets companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| WinVest Acquisition Corp.OTCPK: WINV | $39.33M | $— | — |
| LOM Financial LimitedBER: LOM.BH | $39.17M | BMD— | — |
| Financière Marjos SAENXTPA: FINM | $39.13M | €1.75 | +1.16% |
| MKVentures Capital LimitedBSE: 514238 | $39.09M | Rs984.40 | -5.78% |
| Stock3 AGXTRA: BOG | $38.88M | €31.00 | -1.90% |
| Mayberry Group LimitedJMSE: MGL | $38.47M | J$5.09 | -6.95% |
| Aimei Health Technology Co., LtdNasdaqGM: AFJK | $38.34M | $12.11 | 0.00% |
| Eagle Capital Growth Fund, Inc.NYSEAM: GRF | $38.33M | $9.66 | -4.91% |
Figures last refreshed Oct 11, 2026.